BioSpace News Archive

Kiromic BioPharma Announces Deltacel ™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center.

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2023, and provided operating and partner program updates.

Inozyme Pharma, Inc. today announced that Douglas A. Treco, Ph.D., the Company’s chief executive officer and chairman of the board, will participate at the following investor conferences.

Disc Medicine, Inc. reported financial results for the third quarter ended September 30, 2023, and provided an update on recent program and corporate developments.

Milestone Scientific Inc. announced that it has commenced sales of CompuFlo® Epidural disposables into Island Ambulatory Surgery Center, a multi-specialty ambulatory surgery center based in Brooklyn, New York with a focus on pain management, orthopedics and spine care, urology, podiatry and plastic surgery.

Vaxcyte, Inc. today announced that the first participants were dosed in a Phase 1/2 clinical study for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), in adults.

Viracta Therapeutics today provided a business update and reported financial results for the third quarter of 2023.

Evoke Pharma, Inc. announced its financial results for the third quarter ended September 30, 2023, and recent corporate developments.

Pharma Two B, a private, late-stage pharmaceutical company, today announced that data from a Phase 3 study evaluating P2B001, a fixed, low-dose extended-release (ER) combination of pramipexole 0.6 mg and rasagiline 0.75 mg, were published in Movement Disorders.

AnHeart Therapeutics today announced the appointments of Guilin Huang as Senior Vice President, Development and Amy Muse as Vice President, U.S. Commercial.